Bravecto - 1000mg - Single

Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs.

Last up 12 weeks.

The following tablet strengths are:
Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg)
Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg)
Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg)
Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg)
Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).

Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs.

Last up 12 weeks.

The following tablet strengths are:
Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg)
Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg)
Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg)
Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg)
Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).

Bravecto Plus spot-on solution for cats is a product for topical application containing fluralaner and moxidectin. It is for the treatment and prevention of flea and tick infestations and for the treatment of certain worms (roundworms (Toxocara cati), hookworms (Ancylostoma tubaeforme) and heartworm (Dirofilaria immitis) in cats.

For cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites, gastrointestinal nematodes or heartworm. The veterinary medicinal product is exclusively indicated when used against ticks or fleas and one or more of the other target parasites is indicated at the same time.

For the treatment of tick and flea infestations in cats providing immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
For the treatment of infestations with ear mites (Otodectes cynotis).
For the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults of Toxocara cati) and hookworm (4th stage larvae, immature adults and adults of Ancylostoma tubaeforme).

When administered repeatedly at a 12-week interval, the product continuously prevents heartworm disease caused by Dirofilaria immitis.

Packaging Quantities
Bravecto 112.5 mg / 5.6mg spot-on solution for small cats (1.2 – 2.8 kg)
Bravecto 250 mg / 12.5 mg spot-on solution for medium-sized cats (>2.8 – 6.25 kg)
Bravecto 500 mg / 25 mg spot-on solution for large cats (>6.25 – 12.5 kg)

Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs.

Last up 12 weeks.

The following tablet strengths are:
Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg)
Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg)
Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg)
Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg)
Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).